enloplatin has been researched along with Cancer of Ovary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Edwards, CL; Freedman, RS; Hord, M; Kavanagh, JJ; Kim, EE; Kudelka, AP; Madden, TL; Mante, R; Rastogi, R; Siddik, ZH; Tornos, C; Tresukosol, D | 1 |
1 trial(s) available for enloplatin and Cancer of Ovary
Article | Year |
---|---|
A phase II and pharmacokinetic study of enloplatin in patients with platinum refractory advanced ovarian carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Glomerular Filtration Rate; Humans; Metabolic Clearance Rate; Middle Aged; Ovarian Neoplasms; Patient Selection; Survival Rate | 1997 |